Beta Bionics, Inc. (BBNX) Cash Flow Statement
Beta Bionics, Inc. (BBNX) generated -$55.8M of operating cash flow over the twelve months to 2026-06-30, spent $5.6M on capital expenditure and had free cash flow of -$61.4M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BBNXBeta Bionics, Inc.Follow BBNX — free
—
Price chart with a free account
- Market cap
- 862.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
| Line | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Operating cash flow | -48.3 | -50.9 | -55.8 | |
| Capital expenditure | 3.4 | 5.3 | -5.6 | |
| Free cash flow | -51.7 | -56.2 | -61.4 | |
| Stock-based compensation | 6.4 | 16.4 | — |
USD millions · SEC XBRL
Beta Bionics, Inc. — questions
- What is Beta Bionics, Inc.'s operating cash flow?
- -$55.8M over the twelve months to 2026-06-30.
- How much does Beta Bionics, Inc. spend on capital expenditure?
- $5.6M over the twelve months to 2026-06-30.
- What is Beta Bionics, Inc.'s free cash flow?
- -$61.4M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Beta Bionics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.